A clinically translatable mouse model for chemotherapy-related fatigue

Area of Science:

• Oncology
• Pharmacology
• Animal Models

Background:

• Fatigue is a common and severe complication of cancer and its treatments.
• Current research on cancer-related fatigue therapies is limited by inconsistent patient data and measurement methods.

Purpose of the Study:

• To establish a reliable animal model for chemotherapy-induced fatigue.
• To validate the model's ability to mimic physical fatigue symptoms and respond to pharmaceutical intervention.

Main Methods:

• Female mice received doxorubicin or saline in two cycles.
• Activity was measured using running wheels and open-field tests; motor coordination was assessed with a rotarod.
• Modafinil was tested for its efficacy in mitigating fatigue symptoms in a separate cohort.

Main Results:

• Doxorubicin treatment significantly reduced wheel running activity by over 30% compared to controls.
• No significant differences were observed in open-field distance or motor coordination between groups.
• Modafinil administration successfully increased wheel running activity in doxorubicin-treated mice.
• Red blood cell counts decreased post-doxorubicin but recovered by study's end.

Conclusions:

• The study successfully established an animal model for chemotherapy-related fatigue, characterized by decreased voluntary activity.
• This model accurately reflects key physical symptoms of cancer-related fatigue.
• The model is suitable for screening and evaluating potential fatigue-alleviating drugs.